These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 34339639
1. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18. Chow EPF, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, Regan DG, Grulich AE, Callander D, Khawar L, Machalek DA, Donovan B. Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639 [Abstract] [Full Text] [Related]
2. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976 [Abstract] [Full Text] [Related]
3. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ. BMJ; 2013 Apr 18; 346():f2032. PubMed ID: 23599298 [Abstract] [Full Text] [Related]
4. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data. Ali H, McManus H, O'Connor CC, Callander D, Kong M, Graham S, Saulo D, Fairley CK, Regan DG, Grulich A, Low N, Guy RJ, Donovan B. Med J Aust; 2017 Mar 20; 206(5):204-209. PubMed ID: 28301790 [Abstract] [Full Text] [Related]
5. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK. Sex Transm Infect; 2015 May 20; 91(3):214-9. PubMed ID: 25305210 [Abstract] [Full Text] [Related]
10. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study. Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK. Lancet Infect Dis; 2017 Jan 20; 17(1):68-77. PubMed ID: 27282422 [Abstract] [Full Text] [Related]
11. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study. Chow EP, Danielewski JA, Fehler G, Tabrizi SN, Law MG, Bradshaw CS, Garland SM, Chen MY, Fairley CK. Lancet Infect Dis; 2015 Nov 20; 15(11):1314-23. PubMed ID: 26201300 [Abstract] [Full Text] [Related]
12. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. Oliphant J, Perkins N. N Z Med J; 2011 Jul 29; 124(1339):51-8. PubMed ID: 21952330 [Abstract] [Full Text] [Related]
14. Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study. Harrison C, Britt H, Garland S, Conway L, Stein A, Pirotta M, Fairley C. PLoS One; 2014 Jul 29; 9(9):e105967. PubMed ID: 25180698 [Abstract] [Full Text] [Related]
16. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017. Checchi M, Mesher D, Mohammed H, Soldan K. Sex Transm Infect; 2019 Aug 29; 95(5):368-373. PubMed ID: 30723186 [Abstract] [Full Text] [Related]
18. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. Ali H, Guy RJ, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Donovan B. BMC Infect Dis; 2013 Mar 18; 13():140. PubMed ID: 23506489 [Abstract] [Full Text] [Related]
20. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H. Euro Surveill; 2018 Oct 18; 23(41):. PubMed ID: 30326995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]